Localized cutaneous leishmaniasis, intralesional treatment
DOI:
https://doi.org/10.29176/2590843X.1810Keywords:
leishmaniasis, cutaneous, infectiousAbstract
Cutaneous leishmaniasis is an infectious dermatosis, caused by protozoa of the genus Leishmania spp. The World Health Organization reports 700,000-1,000,000 cases per year. Its clinical forms include cutaneous leishmaniasis, mucocutaneous leishmaniasis, visceral leishmaniasis, and the diagnosis is established by histopathology, dermoscopy, Montenegro test, and serology. The case of a 38-year-old male with an epidemiological history is presented: recent visit to an endemic area for Leihsmaniasis. Cutaneous phototype IV/VI, who presents dermatosis in the malar region characterized by erythematous plaque with well-defined regular borders with a hematocyst on its surface, without outlet of pruritic secretion of months of evolution. By clinical, epidemiological and histopathological definition, a definitive diagnosis of localized cutaneous leishmaniasis is established, starting treatment with meglumine antimonate, once a week application schedule, 3 ml intralesionally, with intervals of one week between applications, for a period of 8 weeks. with satisfactory evolution after 6 months of treatment.
Author Biographies
Ismar Jeniree Marte Colina, Universidad de Carabobo, Ciudad Hospitalaria “Dr. Enrique Tejera”, Valencia, Estado Carabobo, Venezuela.
Médico residente de tercer año, Posgrado de Dermatología, Universidad de Carabobo, Ciudad Hospitalaria “Dr. Enrique Tejera”, Valencia, Estado Carabobo, Venezuela.
María Gabriela Manzanero Arcila, Universidad de Carabobo, Ciudad Hospitalaria “Dr. Enrique Tejera”, Valencia, Estado Carabobo, Venezuela.
Médico residente de segundo año, Posgrado de Dermatología, Universidad de Carabobo, Ciudad Hospitalaria “Dr. Enrique Tejera”, Valencia, Estado Carabobo, Venezuela.
Mary Lisbeth Soto Pernia, Universidad de Carabobo, Ciudad Hospitalaria “Dr. Enrique Tejera”, Valencia, Estado Carabobo, Venezuela.
Médico residente de segundo año, Posgrado de Dermatología, Universidad de Carabobo, Ciudad Hospitalaria “Dr. Enrique Tejera”, Valencia, Estado Carabobo, Venezuela.
Sandra Carlina Vivas Toro, Universidad de Carabobo, Ciudad Hospitalaria “Dr. Enrique Tejera”, Valencia, Estado Carabobo, Venezuela.
Médico internista, dermatóloga. Magíster en Investigación Educativa. Doctorado en Salud Pública. Profesora ordinaria, Universidad de Carabobo. Jefa, Servicio de Dermatología, Ciudad Hospitalaria “Dr. Enrique Tejera”. Coordinadora, Programa de Posgrado de Dermatología, Universidad de Carabobo. Miembro, Sociedad Venezolana de Dermatología; Sociedad Internacional de Dermatoscopia.
References
World Health Organization. Leishmaniasis [Internet]. 2023 [Citado el 30 de abril de 2023]. Disponible en: https://bit.ly/3fJkKgA
I. Abadías-Granado∗, A. Diago, P.A. Cerro, A.M. Palma-Ruiz e Y. Gilaberte. Leishmaniasis cutánea y mucocutánea. ACTAS Dermo-Sifiliográficas 112 (2021) 601-618. https://doi.org/10.1016/j.ad.2021.02.008
Gallo, S; Jaramillo, F; Van den Enden, L; Galvis, W. Leishmaniasis cutánea crónica en el nuevo mundo. Rev Asoc Colomb Dermatol. Vol 30(2): abril - junio, 2022, 138-147.DOI: https://doi.org/10.29176/2590843X.161
Mendez. B, Oliveira. J, De Brito C, Coura W, et al. Recent advances and new strategies on leishmaniasis treatment. Applied Microbiology and Biotechnology 2020; 104(21):8965-8977. DOI:10.1007/s00253-020-10856-w
Organización Panamericana de la Salud (OPS). Leishmaniasis en las Américas (2013) Recomendaciones para el tratamiento. OPS, Washington, pp 1–60
Bashir U, Tahir M, Anwar MI, Manzoor F. Comparison of intralesional meglumine antimoniate along with oral itraconazole to intralesional meglumine antimoniate in the treatment of cutaneous leishmaniasis. Pak J Med Sci 2019 ;35:1669–1673. DOI:org/10. 12669/pjms.35.6.363
Ramalho DB, Silva RED, Senna MCR, Moreira HAS, Pedras MJ, Avelar DM, Saraiva L, Rabelle A, Cota G (2018) Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a sin- gle arm, open label, phase II clinical trial. Mem Inst Oswaldo Cruz 113:e180200. DOI:org/10.1590/0074-02760180200
Arboleda M, Barrantes S, Úsuga LY, Robledo SM. Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: a case series. Rev Soc Bras Med Trop 2019; 16: e20180211. DOI: org/10.1590/0037-8682-0211-2018
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
